Multiple Myeloma in the Newly Diagnosed Patient: Guidelines and Emerging Data for Managed Care
Sponsored by North American Center for Continuing Medical Education, LLC
Faculty
Presenter/Q&A Cohost
Seema Singhal, MD
Professor of Medicine
Director, Myeloma Program
Robert H. Lurie Comprehensive Cancer Center
Northwestern University
Chicago, Illinois
Q&A Cohost
William J. Cardarelli, PharmD
Director of Pharmacy
Atrius Health
Harvard Vanguard Medical Associates
Watertown, Massachusetts
Target Audience
This activity is designed for managed markets physicians and pharmacists.
Learning Objectives
After completing this activity, participants should be able to:
- Classify the overall goals of multiple myeloma management, including achieving complete response to treatment versus disease control
- Outline current safety and efficacy data for standard and newer therapies for newly diagnosed multiple myeloma
- Examine comorbidities directly and indirectly associated with multiple myeloma and the impact on treatment decisions
- Apply patient-centered, guideline-based approaches to assist clinicians in managing multiple myeloma and minimizing healthcare resource use
Activity Overview
This on-demand slide lecture with audio is available with html slides and the presentation transcript.
To be eligible for documentation of credit, participants must participate in the full activity, complete the online 10-question post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.
Release Date: June 6, 2009
Expiration Date: July 8, 2010
Estimated time to complete: 1 hour
There is no fee associated with this activity.
Participants who have successfully completed the live version of this activity are not eligible to receive credit for this activity.
This educational activity is a knowledge-based activity.
For questions regarding this educational activity, please contact Angela Scarnici at 609-371-1137.
Hardware/Software Requirements
All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape, or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.
CME Accreditation
North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CPE Accreditation
North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education (UAN 276-000-09-023-H01-P).
Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact John Savage, Director, Medical Education, NACCME, in writing, at 300 Rike Drive, Suite A, Millstone Township, NJ 08535, or by e-mail at jsavage@naccme.com. The Director of Medical Education will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Vice President, Medical Education, NACCME, may be made for a second level of review.
Independent Clinical Reviewer: Don M. Benson, Jr, MD, PhD, Assistant Professor of Medicine, Division of Hematology/Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
Planning Committee
The planning committee comprises Seema Singhal, MD, William J. Cardarelli, PharmD, Don M. Benson, Jr, MD, PhD; and Randy Robbin, Rosemary Hodgson, Emilie McCardell, John Savage, and William Kormos, NACCME, and Deborah Neveleff.
Medical writer Deborah Neveleff contributed to the writing and editing of this article.
Financial Disclosure and Conflicts of Interest
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Dr. Benson: Grant/research support—American Cancer Society
Dr. Cardarelli has disclosed no relevant financial relationships with any commercial interests.
Dr. Singhal: Consultant—Celgene, Millennium Pharmaceuticals, Inc.
Mr. Robbin, Ms. Hodgson, Ms. McCardell, Mr. Savage, and Mr. Kormos have disclosed no relevant financial relationships with any commercial interests.
NACCME requires faculty to inform participants whenever off-label/unapproved use(s) of drugs and/or devices are discussed in their presentation.
The faculty has disclosed the following off-label/unapproved use(s) of drugs and/or devices will be discussed: the use of lenalidomide and bortezomib for the treatment of newly diagnosed multiple myeloma.
Privacy Policy
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2009 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.
Grant Support
Supported by an educational grant from Millennium Pharmaceuticals, Inc.
